Topchoice Medical Co., Inc. (SHA:600763)
China flag China · Delayed Price · Currency is CNY
35.49
+0.11 (0.31%)
Aug 26, 2026, 3:00 PM CST

Topchoice Medical Co. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
701.59501.95501500.44548.27702.81
Depreciation & Amortization
200.01190.93203.41189.35173.31153.8
Other Amortization
65.4972.564.4555.2546.135
Loss (Gain) From Sale of Assets
-0.40.27-0.14-0.050.02
Asset Writedown & Restructuring Costs
0.370.360.860.420.510.21
Loss (Gain) From Sale of Investments
-146.09-47.33-47.84-60.19-38.3-56.13
Provision & Write-off of Bad Debts
11.3111.353.171.751.671.29
Other Operating Activities
60.51122.82114.15131.85117.71109.25
Change in Accounts Receivable
-47.66-42.73-28.94-37.77-45.07-46.88
Change in Inventory
-1.7410.22-3.74-1.9-2.55-2.68
Change in Accounts Payable
15.34-3.78-37.371.22-122.1236.97
Change in Other Net Operating Assets
-1.64-1.64-1.64-1.64-1.64-1.64
Operating Cash Flow
855.37810.72762.99841.02670.05939.41
Operating Cash Flow Growth
7.68%6.25%-9.28%25.52%-28.67%32.59%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-218.13-246.2-332.11-508.9-421.53-367.32
Sale of Property, Plant & Equipment
2.152.152.020.010.620.02
Cash Acquisitions
-555-15-27.73---
Divestitures
----0.03-131.95
Investment in Securities
5.2411.11-7.04-504.25-60.45-234.42
Other Investing Activities
-20.15-31.31-96.1-14.47-15.99-14
Investing Cash Flow
-785.89-279.24-324.97-887.63-497.35-483.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-5080280--
Long-Term Debt Repaid
--224.81-252.43-193.57-251.18-241.76
Net Debt Issued (Repaid)
5.05-174.81-172.4386.43-251.18-241.76
Repurchase of Common Stock
---30.1-1-99.99-
Common Dividends Paid
-5.66-208.89-149.89-11.24-6.69-12.87
Other Financing Activities
-183.63-71.32-59.85-63.04-28.33-31.3
Financing Cash Flow
-184.24-455.02-412.2811.15-386.19-285.93

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-114.7576.4625.74-35.46-213.5169.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
637.25564.52430.88332.13248.52572.09
Free Cash Flow Growth
22.05%31.02%29.73%33.64%-56.56%6.33%
Free Cash Flow Margin
20.89%19.38%14.99%11.67%9.14%20.57%
Free Cash Flow Per Share
1.431.260.960.740.551.27
Levered Free Cash Flow
367.33330.95375.96331.44-199.6365.3
Unlevered Free Cash Flow
378.2353.36404.36365.82-168.32383.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
179.47153.52162.07142.52227.01105.67
Change in Working Capital
-37.42-42.12-76.0622.15-179.26-6.83